REELI REINU: Open Payments
NPI 1609884253 · MAITLAND, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$140,137 in 334 payments from 21 companies in 2025. Trend: 2023 $86,874 · 2024 $127,928 · 2025 $140,137
Speaker / faculty: $93,601Travel & lodging: $26,755Consulting: $13,888Food & beverage: $5,622Education: $271
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 190 | $137,694 |
| ABBVIE INC. | 30 | $312 |
| Galderma Laboratories, L.P. | 32 | $275 |
| UCB, Inc. | 8 | $275 |
| Regeneron Healthcare Solutions, Inc. | 7 | $253 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 9 | $244 |
| LEO Pharma Inc. | 8 | $190 |
| GENZYME CORPORATION | 7 | $137 |
| Lilly USA, LLC | 12 | $131 |
| Organon LLC | 10 | $109 |
Products named: TREMFYA, DUPIXENT, Bimzelx, ADBRY, RINVOQ, ILUMYA, NEMLUVIO, SKYRIZI.
Industry payments across FL — which companies pay providers there.
